Back to Search
Start Over
Mulberry and Hippophae -based solid beverage promotes weight loss in rats by antagonizing white adipose tissue PPARĪ³ and FGFR1 signaling.
- Source :
-
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Mar 15; Vol. 15, pp. 1344262. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Obesity, a multifactorial disease with many complications, has become a global epidemic. Weight management, including dietary supplementation, has been confirmed to provide relevant health benefits. However, experimental evidence and mechanistic elucidation of dietary supplements in this regard are limited. Here, the weight loss efficacy of MHP, a commercial solid beverage consisting of mulberry leaf aqueous extract and Hippophae protein peptides, was evaluated in a high-fat high-fructose (HFF) diet-induced rat model of obesity. Body component analysis and histopathologic examination confirmed that MHP was effective to facilitate weight loss and adiposity decrease. Pathway enrichment analysis with differential metabolites generated by serum metabolomic profiling suggests that PPAR signal pathway was significantly altered when the rats were challenged by HFF diet but it was rectified after MHP intervention. RNA-Seq based transcriptome data also indicates that MHP intervention rectified the alterations of white adipose tissue mRNA expressions in HFF-induced obese rats. Integrated omics reveals that the efficacy of MHP against obesogenic adipogenesis was potentially associated with its regulation of PPARĪ³ and FGFR1 signaling pathway. Collectively, our findings suggest that MHP could improve obesity, providing an insight into the use of MHP in body weight management.<br />Competing Interests: Authors X-ML, J-GY, S-SC, and X-LM were employed by the company Perfect Guangdong Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Zhou, Zhu, Li, Sun, Yan, Luo, Chen, Huang, Mao and Li.)
Details
- Language :
- English
- ISSN :
- 1664-2392
- Volume :
- 15
- Database :
- MEDLINE
- Journal :
- Frontiers in endocrinology
- Publication Type :
- Academic Journal
- Accession number :
- 38559696
- Full Text :
- https://doi.org/10.3389/fendo.2024.1344262